Company Overview of E. Merck KG
E. Merck KG operates as a general partner for Merck KGaA, which develops, manufactures, and distributes pharmaceutical products. The company is based in Darmstadt, Germany.
Frankfurter Strasse 250
Key Executives for E. Merck KG
Chairman of the Executive Board of Merck KGaA and Chief Executive Officer at Merck KGaA
Member of executive Board
Compensation as of Fiscal Year 2015.
E. Merck KG Key Developments
E. Merck KG Announces Management Changes, Effective January 1, 2015
Sep 18 14
Merck KGaA announced E. Merck KG has appointed Stefan Oschmann to the position of Vice Chairman and Deputy CEO. Concurrently, Bel n Garijo has been appointed to the Executive Board to take over leadership for the Pharma business. The management changes will be effective as of January 1, 2015. Oschmann, currently CEO Pharma, will represent Karl-Ludwig Kley, Chief Executive Officer and Chairman of the Executive Board, in hisresponsibilities. Both will share strategic management functions and represent the company with politicians and international organizations. As a member of the Executive Board, Garijo, currently CEO of Merck's biopharmaceutical division Merck Serono, will assume responsibility for the whole Pharma business, which in addition to Merck Serono comprisesConsumer Health, Allergy and Biosimilars.
E. Merck KG Announces Board Changes
Feb 6 14
E. Merck KG has appointed Frank Stangenberg-Haverkamp as the new chairman of the twelve-member family board. Jon Baumhauer (69), previously Chairman of the Family Board and Chairman of the Executive Board of E. Merck KG, has retired from his offices for age reasons. Stangenberg-Haverkamp, who has been a member of the Board of Partners since 1984, has been elected Vice Chairman.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries